Trevi Therapeutics (TRVI) Change in Account Payables (2018 - 2026)
Trevi Therapeutics' quarterly Change in Account Payables came in at -$1.5 million in Q1 2026, up 25.59% year-on-year from -$1.2 million in Q1 2025, and down 1305.69% quarter-over-quarter from $123000.0 in Q4 2025.
Trevi Therapeutics has reported Change in Account Payables for 9 years, with the latest figure at -$1.5 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 25.59% year-over-year to -$1.5 million; the trailing twelve-month figure through Mar 2026 stood at -$88000.0 (up 87.1% YoY), and the FY2025 full-year result was -$598000.0, down 137.26% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$1.5 million, down from $123000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $2.1 million in Q2 2022, with the low at -$2.0 million in Q1 2025.
- Average Change in Account Payables over 5 years is -$89176.5, with a median of -$170000.0 recorded in 2023.
- Peak annual rise in Change in Account Payables reached 351.46% in 2025, while the deepest fall reached 777.89% in 2025.
- Tracing TRVI's Change in Account Payables over 5 years: stood at $536000.0 in 2022, then gained by 16.98% to $627000.0 in 2023, then jumped by 186.92% to $1.8 million in 2024, then slumped by 93.16% to $123000.0 in 2025, then plunged by 1305.69% to -$1.5 million in 2026.
- The last three Change in Account Payables figures came in at -$1.5 million (Q1 2026), $123000.0 (Q4 2025), and -$282000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - | -1.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.48 Mn |
| Mar 31, 2026 | -1.48 Mn |
| Dec 31, 2025 | 123,000.00 |
| Dec 31, 2025 | 123,000.00 |
| Sep 30, 2025 | -282,000.00 |
| Sep 30, 2025 | -282,000.00 |
| Jun 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 1.55 Mn |
| Mar 31, 2025 | -1.99 Mn |
| Mar 31, 2025 | -1.99 Mn |
| Dec 31, 2024 | 1.80 Mn |
| Dec 31, 2024 | 1.80 Mn |
| Sep 30, 2024 | 130,000.00 |
| Sep 30, 2024 | 130,000.00 |
| Jun 30, 2024 | -618,000.00 |
| Jun 30, 2024 | -618,000.00 |
| Mar 31, 2024 | 294,000.00 |
| Mar 31, 2024 | 294,000.00 |
| Dec 31, 2023 | 627,000.00 |
| Dec 31, 2023 | 627,000.00 |
| Sep 30, 2023 | -170,000.00 |
| Sep 30, 2023 | -170,000.00 |
| Jun 30, 2023 | -592,000.00 |
| Jun 30, 2023 | -592,000.00 |
| Mar 31, 2023 | -914,000.00 |
| Mar 31, 2023 | -914,000.00 |
| Dec 31, 2022 | 536,000.00 |
| Dec 31, 2022 | 536,000.00 |
| Sep 30, 2022 | -1.47 Mn |
| Sep 30, 2022 | -1.47 Mn |
| Jun 30, 2022 | 2.05 Mn |
| Jun 30, 2022 | 2.05 Mn |
| Mar 31, 2022 | -1.11 Mn |
| Mar 31, 2022 | -1.11 Mn |
| Dec 31, 2021 | 615,000.00 |
| Dec 31, 2021 | 615,000.00 |
| Sep 30, 2021 | -1.26 Mn |
| Sep 30, 2021 | -1.26 Mn |
| Jun 30, 2021 | 2.69 Mn |
| Jun 30, 2021 | 2.69 Mn |
| Mar 31, 2021 | -1.22 Mn |
| Mar 31, 2021 | -1.22 Mn |
| Dec 31, 2020 | 758,000.00 |
| Dec 31, 2020 | 758,000.00 |
| Sep 30, 2020 | -1.90 Mn |
| Sep 30, 2020 | -1.90 Mn |
| Jun 30, 2020 | 967,000.00 |
| Jun 30, 2020 | 967,000.00 |
| Mar 31, 2020 | 594,000.00 |
| Mar 31, 2020 | 594,000.00 |
| Dec 31, 2019 | 1.11 Mn |
| Dec 31, 2019 | 1.11 Mn |
| Sep 30, 2019 | -2.05 Mn |
| Sep 30, 2019 | -2.05 Mn |
| Jun 30, 2019 | 1.90 Mn |
| Jun 30, 2019 | 1.90 Mn |
| Mar 31, 2019 | -185,000.00 |
| Mar 31, 2019 | -185,000.00 |
| Dec 31, 2018 | -58,000.00 |
| Dec 31, 2018 | -58,000.00 |
| Sep 30, 2018 | -56,000.00 |
| Sep 30, 2018 | -56,000.00 |
| Jun 30, 2018 | 71,000.00 |
| Jun 30, 2018 | 71,000.00 |
| Mar 31, 2018 | 109,000.00 |
| Mar 31, 2018 | 109,000.00 |